Leading CIOs honored for leadership, innovation, and business impact. NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The 2025 ...

Cost of revenues for the nine months ended September 30, 2025 totaled $7.9 million compared to $11.4 million in the same period last year. The decrease was primarily due to a decrease in jet card and ...

In both fatal cases, patients developed markedly elevated liver enzymes and required hospitalization within two months of Elevidys infusion. An additional serious, non-fatal case of acute liver injury ...

PetVivo Holdings, Inc. (OTCQX: PETV; OTC ID: PETVW), through its wholly owned subsidiary Petvivo Animal Health, a leading biomedical company delivering innovative medical devices and therapeutics for ...

America’s Top Financial Advisory Firms award received in 2026 were granted by Newsweek, with assistance from Plant-A Insights Group. McAdam LLC did not apply for or pay for the award. The ranking of ...

Investors probably aren't getting the economic data they've been missing, even with the shutdown ending. Rate-cut views for ...

Moody's economist Mark Zandi warns that the trend of deglobalization will act as a headwind that could offset the boost ...

CoreWeave stock price fell sharply on Tuesday on mixed Q3 results. While the AI darling's revenue more than doubled, its also ...

Presented new data at the Society of Immunotherapy for Cancer (SITC) annual meeting on CLD-401 protection from immune clearance after systemic ...

CERRITOS, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, ...

Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing next-generation targeted therapies for patients with immune-mediated diseases, today reported financial results for ...

On October 15, 2025, the Company paid a cash dividend of $0.30 per common share for the third quarter of 2025. SUNS distributed $4.0 million in dividends, or $0.30 per common share, compared to ...